Navigation Links
Most Drug Studies Don't Help Docs Pick Best Treatment
Date:3/9/2010

The problem? Available meds ignored in favor of drugs in the pipeline, review finds

TUESDAY, March 9 (HealthDay News) -- Less than one-third of drug studies published in major medical journals answer the fundamental question of which of the range of available medications works best for a particular condition.

So concludes the first wide-scale look at so-called "comparative effectiveness" studies, where experts seek to determine which available medicine is likely to prove most cost-effective for patients. The findings are published in the March 10 issue of the Journal of the American Medical Association.

A focus on comparative effectiveness has been a hallmark of the federal government's attempts to gain the most from scarce health-care dollars, and in 2009 Congress earmarked over $1 billion for this type of research.

But the new report found that just 32 percent of the 328 drug studies reviewed involved comparisons of medicines that were currently available. The rest involved either drugs in development, or they pitted available drugs against no treatment or a placebo. The studies appeared in six of the leading medical journals between June 2008 and September 2009.

"Research on new therapies is critical for scientific advancement, but we also need data that will help doctors use existing therapies appropriately," study author Dr. Michael Hochman, of the Keck School of Medicine at the University of Southern California, explained in a news release from the Cambridge Health Alliance.

"We need research that addresses questions such as: Which of the more than 30 blood pressure medications on the market works best and in whom?" Hochman said. "Are certain diets and exercise regimens as good as medications for controlling cholesterol? Is it safe to aim for normal blood sugar levels when treating patients with diabetes? Such information is critical for day-to-day medical decision-making."

<
'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Promega - TOP srl Agreement Enables Live Animal Imaging for Cancer Studies
2. COPPERTONE(R) Solar Research Center Unveils Studies on Efficacy of Topical Antioxidants in Sunscreens at 2010 Annual Meeting of The American Academy of Dermatology
3. Studies Detail Possible Benefits of omega-3 Fatty Acids for Dogs With Arthritis
4. Second Dose of Gene Therapy for Inherited Blindness Proves Safe in Animal Studies
5. UC studies show marijuana has therapeutic value, reports to legislature
6. New Scientific Studies Show Further Evidence of Avandia Dangers
7. Barrow researchers receive more than $2 million in NIH grants for nicotine studies
8. Studies Show Doctors Rapidly Forget Critical, Life-Saving Skills such as CPR and Life Support
9. PRA International Rolls out Client Access to Oracle(R) RDC for Early Phase Studies
10. Soil studies reveal rise in antibiotic resistance
11. Chicago Cancer Genome Project studies genetics of 1,000 tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... technology and services, today announced that its fifth annual Smile for a Lifetime ... $80,000 for the non-profit organization. In addition to supporting S4L in its mission ...
(Date:7/1/2015)... ... 01, 2015 , ... The Collaborative for Children and Families (CCF) announced that ... will allow CCF to improve quality of care and save costs for the child ... to many changes in New York’s Medicaid system. Experts agree that children need thorough ...
(Date:7/1/2015)... ... 2015 , ... During the first week of June, Alamo ... Development) and Chuck Corso (Associate Sales Trainer) participated in the 44th Annual Life ... learning and development professionals from more than 300 life sciences companies around the ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... As if ... symptom found in a significant number of women: leg pain. Northeast Houston Vein Center ... Leg pain, a symptom of venous reflux disease, is underdiagnosed and often overlooked. Many ...
(Date:7/1/2015)... ... 2015 , ... RowdMap Inc. is a proud participant on ... Identifying the High-Cost Patient Population: Insights from the Health Care Transformation Task Force.” ... . , The Healthcare Transformation Task Force is a group of private sector ...
Breaking Medicine News(10 mins):Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 2Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 3Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 2Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 2Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 4Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 2Health News:Northeast Houston Vein Center Offers Tips for Women with Leg Pain 3Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 3
... Professional Services Team Updates Television Infrastructure to Enable ... Technology EnhancementsSIOUX FALLS, S.D., May 19 LodgeNet ... LNET ) and the leading provider ... its LodgeNetRX(R) Interactive Patient Television System is now ...
... Needed to Focus Policy Actions at the Federal Level , ... ... Hepatitis Day , more than 200 viral hepatitis groups around the ... international and national support for improvements in prevention, diagnosis, treatment and ...
... 19 The Quigley Corporation, (Nasdaq: ... , today announced that it has uncovered ... Company,s Quigley Pharma, Inc. wholly-owned subsidiary COO, Dr. Richard ... documentary evidence of undisclosed payments from Karkus to Rosenbloom ...
... offers pet owners the keys to stress-free travel with your ... families hit the road for a getaway. For those ... a stress-free holiday and a trip filled with anxiety for ... ) is dedicated to providing pet owners the tools ...
... (NYSE: DGX ), the world,s leading provider of ... commenced a cash tender offer to purchase up to $200 ... Senior Notes due 2010 and 7.50% Senior Notes due 2011 ... offer are described in the Offer to Purchase dated May ...
... Hospital websites earn top honorsTROY, Mich., May 19 ... ), an information technology (IT) and Web products and ... honored for medical marketing excellence, earning two gold awards ... ) competition for its Web products and strategies supporting ...
Cached Medicine News:Health News:LodgeNet Healthcare Announces Deployment of Interactive Patient Television System in Oklahoma Heart Hospital 2Health News:LodgeNet Healthcare Announces Deployment of Interactive Patient Television System in Oklahoma Heart Hospital 3Health News:National Viral Hepatitis Roundtable Observes World Hepatitis Day and Calls for Increased Federal Action 2Health News:National Viral Hepatitis Roundtable Observes World Hepatitis Day and Calls for Increased Federal Action 3Health News:Dissident Stockholder Ted Karkus Found to Have Undisclosed Financial Arrangements With Dr. Richard A. Rosenbloom, COO Of Quigley Pharma, From 2008 to Date of Proxy: Rosenbloom Suspended Without Pay Pending Further Investigation 2Health News:Dissident Stockholder Ted Karkus Found to Have Undisclosed Financial Arrangements With Dr. Richard A. Rosenbloom, COO Of Quigley Pharma, From 2008 to Date of Proxy: Rosenbloom Suspended Without Pay Pending Further Investigation 3Health News:Dissident Stockholder Ted Karkus Found to Have Undisclosed Financial Arrangements With Dr. Richard A. Rosenbloom, COO Of Quigley Pharma, From 2008 to Date of Proxy: Rosenbloom Suspended Without Pay Pending Further Investigation 4Health News:Dissident Stockholder Ted Karkus Found to Have Undisclosed Financial Arrangements With Dr. Richard A. Rosenbloom, COO Of Quigley Pharma, From 2008 to Date of Proxy: Rosenbloom Suspended Without Pay Pending Further Investigation 5Health News:Top 10 Pet Travel Tips for Memorial Day 2Health News:Quest Diagnostics Commences Cash Tender Offer for Up to $200 Million Aggregate Principal Amount of Certain of its Outstanding Notes 2Health News:Quest Diagnostics Commences Cash Tender Offer for Up to $200 Million Aggregate Principal Amount of Certain of its Outstanding Notes 3Health News:Quest Diagnostics Commences Cash Tender Offer for Up to $200 Million Aggregate Principal Amount of Certain of its Outstanding Notes 4Health News:CareTech Receives National Recognition in 2009 Aster Awards for Medical Marketing Excellence 2Health News:CareTech Receives National Recognition in 2009 Aster Awards for Medical Marketing Excellence 3
(Date:7/1/2015)... , July 1, 2015 Prismic Pharmaceuticals, Inc., ... FDA-regulated medical foods, today announced the election of ... to its Board of Directors. Commenting ... Peter Moriarty , Chairman and CEO of Prismic, ... and Martin Simonetti have accepted our invitation ...
(Date:7/1/2015)... YORK, Pa. , July 1, 2015  Unilife ... developer, manufacturer and supplier of injectable drug delivery systems, ... been amended as of June 30, 2015. This amendment ... least $20 million in cash receipts from customers during ... no other adjustments to any of the terms of ...
(Date:7/1/2015)... July 1, 2015  Imprimis Pharmaceuticals, Inc. (NASDAQ: ... the development and commercialization of proprietary compounded drug ... The Nasdaq stock market closing bell on Thursday, ... success of its Go Dropless™ campaign since its ... procedures are performed annually in the U.S. and ...
Breaking Medicine Technology:Joseph Krivulka and Martin Simonetti Join Board of Prismic Pharmaceuticals 2Unilife and OrbiMed Amend Debt Financing Agreement 2Unilife and OrbiMed Amend Debt Financing Agreement 3Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 2Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 3Imprimis Pharmaceuticals to Ring The Nasdaq Stock Market Closing Bell 4
... and health care payer and provider organizations convened at the "Selling Pharmaceuticals in 2015" forum in ... drugs on price, features and benefits with a new model that focuses on quantifying and communicating total ... ... , ...
... platform technology designed to standardize hyperthermic perfusion treatments, today announced the appointment of Alan Hirschman , PhD to its Board of Directors. , ... , ... ... ...
Cached Medicine Technology:Drug Makers Discuss New Ways to Trim Health Care Costs at ZS Associates and eyeforpharma Forum 2Drug Makers Discuss New Ways to Trim Health Care Costs at ZS Associates and eyeforpharma Forum 3Drug Makers Discuss New Ways to Trim Health Care Costs at ZS Associates and eyeforpharma Forum 4Drug Makers Discuss New Ways to Trim Health Care Costs at ZS Associates and eyeforpharma Forum 5Drug Makers Discuss New Ways to Trim Health Care Costs at ZS Associates and eyeforpharma Forum 6Drug Makers Discuss New Ways to Trim Health Care Costs at ZS Associates and eyeforpharma Forum 7Drug Makers Discuss New Ways to Trim Health Care Costs at ZS Associates and eyeforpharma Forum 8ThermalTherapeutic Systems, Inc. Announces the Addition of Former MEDRAD Executive Alan Hirschman, PhD to the Board of Directors 2ThermalTherapeutic Systems, Inc. Announces the Addition of Former MEDRAD Executive Alan Hirschman, PhD to the Board of Directors 3
Fine abrasive for knife sharpening, 6 grams net...
Knife sharpening back for Standard Knife, C Profile...
Standard knife with box, C profile...
... Cryostage freezing stage is a refrigerated design for ... primarily for use with the 8000 sledge microtome, ... microtomes. ,The refrigerated stage gives a large working ... is ridged to provide good adhesion between the ...
Medicine Products: